Presentation is loading. Please wait.

Presentation is loading. Please wait.

What’s New with KASPER A Lot! Facilitator: Dr. Michelle Lofwall, UK Associate Professor of Psychiatry Panelists: Dave Hopkins, KASPER Program Manager Van.

Similar presentations


Presentation on theme: "What’s New with KASPER A Lot! Facilitator: Dr. Michelle Lofwall, UK Associate Professor of Psychiatry Panelists: Dave Hopkins, KASPER Program Manager Van."— Presentation transcript:

1 What’s New with KASPER A Lot! Facilitator: Dr. Michelle Lofwall, UK Associate Professor of Psychiatry Panelists: Dave Hopkins, KASPER Program Manager Van Ingram, Executive Director, Kentucky Office of Drug Control Policy Dr. Ryan Stanton, Medical Director ER, UK Good Samaritan Hospital

2 Controlled Substances Dispensed Cabinet for Health and Family Services

3 KASPER Reports Requested Cabinet for Health and Family Services

4 Top Prescribed Controlled Substances by Therapeutic Category by Doses - 2012 Hydrocodone 41.5% Lortab Lorcet Vicodin Alprazolam 11.8% Xanax Tramadol 6.9% Ultram Oxycodone 15.9% OxyContin Percodan Percocet Clonazepam 6.6% Klonopin Diazepam 4.5% Valium Phentermine 2.4% Adipex-P Amphetamine 2.7% Adderall Zolpidem 3.5% Ambien Lorazepam 4.0% Ativan

5 Cabinet for Health and Family Services KASPER Stakeholders Licensing Boards – to investigate potential inappropriate prescribing by a licensee. Practitioners and Pharmacists – to review a current patient’s controlled substance prescription history for medical and/or pharmaceutical treatment. Law Enforcement Officers, OIG employees, Commonwealth’s attorneys, county attorneys - to review an individual’s controlled substance prescription history as part of a bona fide drug investigation or drug prosecution. Medicaid – to screen members for potential abuse of pharmacy benefits and to determine “lock-in”; to screen providers for adherence to prescribing guidelines for Medicaid patients. A judge or probation or parole officer – to help ensure adherence to drug diversion or probation program guidelines.

6 Cabinet for Health and Family Services KASPER Usage 2012 Law Enforcement =.4% (17% of KY LE have accounts) Prescribers = 97.9% (83% of KY prescribers have accounts) Pharmacists = 1.6% (83% of KY pharmacists have accounts) Judges, Other =.1%

7 Cabinet for Health and Family Services eKASPER Master Accounts 12/31/201104/24/201207/20/201212/31/2012 Doctor*5,470 5,680 11,923 16,740 APRN690 781 1,523 1,866 Pharmacist1,385 1,450 3,602 4,888 Total7,545 7,911 17,048 23,494 *Includes physicians, dentists, optometrists and podiatrists

8 Cabinet for Health and Family Services HB1 Early Results DrugAug-Nov 2011Aug-Nov 2012Change Hydrocodone81,125,72171,372,106-12.0% Oxycodone29,768,54626,256,240-11.8% Oxymorphone679,621380,353- 44.0% Alprazolam24,877,99821,277,555-14.5% Methylphenidate3,551,1293,722,988+ 4.8% Amphetamine 4,528,8054,873,753+ 7.6% All Controlled Substances 251,848,764222,487,691-11.7% Figures shown in doses dispensed

9 KASPER Web Site: www.chfs.ky.gov/KASPER


Download ppt "What’s New with KASPER A Lot! Facilitator: Dr. Michelle Lofwall, UK Associate Professor of Psychiatry Panelists: Dave Hopkins, KASPER Program Manager Van."

Similar presentations


Ads by Google